Strides Pharma Science to acquire Endo's manufacturing facility in US along with basket of ANDAs

Strides said the facility at Chestnut Ridge, New York has an annual capacity of 2 billion units across semi- solids, liquids, nasal sprays along with oral solids.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3Aj37c6
via IFTTT